More childhood cancer survivors are experiencing cardiomyopathy and other cardiotoxicities years after treatment with anthracyclines than previously thought, say researchers who have reported the first outcomes from an Australian cohort of paediatric cancer survivors. Cardiologists and oncologists are now calling on national bodies to fund a paediatric cancer survivor register and are urging doctors to ...
Cardiotoxicity risk from anthracyclines lifelong
By Sunalie Silva
18 May 2017